Evaluation of ranibizumab on the ease of procedure and complication rate in proliferative diabetic retinopathy (PDR) requiring vitrectomy
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic retinopathy
- Focus Registrational; Therapeutic Use
- 27 Aug 2007 New trial record.